-
Product Insights
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2023
Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Drugs In Development, 2023’, provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Biologic For Oncology in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Biologic For Oncology in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Biologic For Oncology in Solid Tumor Drug Details:Biologic is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Biologic For Oncology in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Biologic For Oncology in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Biologic For Oncology in Pancreatic Ductal AdenocarcinomaDrug Details:Biologic is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vvax-001 in Human Papillomavirus (HPV) Associated Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vvax-001 in Human Papillomavirus (HPV) Associated Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Vvax-001 in Human Papillomavirus (HPV) Associated CancerDrug Details:Vvax-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linavonkibart in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linavonkibart in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Linavonkibart in Solid TumorDrug Details:SRK-181 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Kevetrin in Epithelial Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Kevetrin in Epithelial Ovarian Cancer Drug Details:Kevetrin (4-Isothioureidobutyronitrile hydrochloride, Kevetrin hydrochloride) is under development for the...
-
Company Profile
The Hain Celestial Group Inc – Company Profile
The Hain Celestial Group Inc (Hain Celestial) manufactures and markets organic and natural products. The company’s product portfolio includes infant, toddler, and kid food products, rice, and grain-based products, plant-based beverages and frozen desserts, flour and bakery products, cereal bars, canned, chilled fresh, aseptic, and instant soups and yogurts. Hain Celestial markets products under Soy Dream, The Greek Gods, Spectrum, Sun-Pat, Westbrae, Natumi, Ella’s Kitchen, and Celestial Seasonings brand names. The company sells its products through specialty and natural food...
Add to Basket -
Product Insights
RPAI – The Ella at Carillon – Maryland
Equip yourself with the essential tools needed to make informed and profitable decisions with our RPAI - The Ella at Carillon - Maryland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Satori – Ella Bay Integrated Resort Development – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Satori - Ella Bay Integrated Resort Development - Queensland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Rex Lumber – Austin Ella Hotel Expansion – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Rex Lumber - Austin Ella Hotel Expansion - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...